Hi,
moomoo ID:0
Log Out
English
Back
Log in to access Online Inquiry

Today's Pre-Market Stock Movers: PEP, MRNA, BGNE, CCJ and More

avatar
Movers and Shakerswrote a column10/12/2022 20:31
  Follow
Gapping up
In reaction to earnings/guidance:
Other news:
$Cango(CANG.US)$ +23.5% (approves special dividend of $0.50 per ordinary share or $1 per ADS)
$El Pollo Loco(LOCO.US)$ +12.7% (declares $1.50/sh special div; also authorizes new $20 mln share repurchase program)
$KnowBe4(KNBE.US)$ +11.4% (KnowBe4 is close to a deal to be acquired by Vista Equity Partners according to WSJ)
$Autolus Therapeutics(AUTL.US)$ +9.1% (announces that Moderna has exercised its option to license Autolus’ proprietary binders against an undisclosed immuno-oncology target for the development and commercialization of mRNA therapeutics)
$Gatos Silver(GATO.US)$ +8.5% (increases production guidance and lowers cost guidance for 2022)
$Rocket Pharmaceuticals(RCKT.US)$ +4.5% (Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy)
$Sangamo Therapeutics(SGMO.US)$ +4.2% (Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated a-Gal A Enzyme Activity in Nine Patients)
$AllianceBernstein Holding(AB.US)$ +4.1% (reports September AUM)
$Earthstone Energy(ESTE.US)$ +4% (purchases 3 mln shares from Warburg Pincus)
$Grindrod Shipping(GRIN.US)$ +3.5% (Announces Agreement With Taylor Maritime Investments Limited)
$Angi Inc(ANGI.US)$ +3.4% (reports Sept performance metrics)
$RCM Technologies(RCMT.US)$ +3.4% (acquires TalentHerder)
$Amarin(AMRN.US)$ +3.3% (issues statement in response to Sarissa)
$Moderna(MRNA.US)$+3% (Moderna & Merck (MRK) announce exercise of option by Merck for joint development and commercialization of investigational personalized cancer vaccine)
$ATAI Life Sciences(ATAI.US)$ +3% (positive initial results for phase 1 trial of KUR-101 an oral formulation of mitragynine for OUD)
$Universal Insurance Holdings Inc(UVE.US)$ +2.3% (provides update on Hurricane Ian impact)
$BeiGene(BGNE.US)$ +2.3% (announces positive topline results from final progression-free survival analysis of BRUKINSA (zanubrutinib) Compared to IMBRUVICA (ibrutinib) in Phase 3 Chronic Lymphocytic Leukemia Trial)
$GreenLight Biosciences(GRNA.US)$ +2% (announces realignment to focus on near-term value drivers)
Gapping down
In reaction to earnings/guidance:
$Owens & Minor(OMI.US)$ -8.6% (lowers guidance; names new CFO),$Royal Philips(PHG.US)$ -8.2%
Other news:
$Cameco(CCJ.US)$ -12.4% (CCJ and BEP form partnership to acquire Westinghouse Electric; also announces $650M bought deal offering; also provides Q3 operating update)
$TRICON RESIDENITAL INC(TCN.US)$ -2.7% (sells interest in multi-family portfolio)
$CTO Realty Growth(CTO.US)$ -2.4% (files $500 mln mixed securities shelf offering)
$BigBear.ai Holdings(BBAI.US)$ -1.6% (CEO steps down; names former IBM exec as new CEO)
$Eagle Pharmaceuticals(EGRX.US)$ -1.3% (files $200 mln mixed securities shelf offering; also submitted an investigational new drug application to the FDA for CAL02 for the treatment of severe community-acquired bacterial pneumonia)
Moomoo is an app offered by Moomoo Technologies Inc. that provides information about investments. Moomoo Technologies is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of Moomoo Technologies, its affiliates, or any employees of Moomoo Technologies or its affiliates. You are advised to consult a qualified financial or tax advisor for your personal financial planning and tax situations. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.
74K Views
Comment
Report
avatar
Movers and Shakers
Posts779Followers35K
  Follow
Comment
Sign in to post a comment